Abstract
The use of irreversible electroporation (IRE) for cancer treatment has increased during the past decade due to many advantages over other focal therapies. However, despite early success in pre-clinical and clinical IRE trials, in vivo studies have shown that IRE suffers from an inability to destroy large volumes of cancer tissue without repeating treatment and/or increasing the applied electrical dose to dangerous levels. The present work demonstrates a simple method whereby treatment volumes can be enhanced by changing pulse timing (delivering pulsing in three trains, 30 s apart), without changing the electrical dose (51 pulses at pulse strengths of 600 V, durations of 50 µs, and repetition rates of 10 Hz), during IRE in a 3D hindlimb tumor model. Results show that 3 weeks of tumor growth delay was achieved with pulse timing compared to 1 week in baseline IRE (200% increase). Furthermore, the pulse timing approach does not introduce any foreign molecules into the body and can easily be integrated into existing treatment or enhancement protocols of IRE. The enhanced injury may correlate to longer pore exposures, or time during which pores exist on the membrane during pulse timing. This in turn increases the likelihood of membrane failure, and/or death from secondary injury such as loss of critical ions, proteins and other cellular components. In summary this work demonstrates a simple translational approach to increase 3D IRE treatment volumes in vivo by using pulse timing.
Similar content being viewed by others
References
Al-Sakere, B., F. André, C. Bernat, E. Connault, P. Opolon, R. V. Davalos, B. Rubinsky, and L. M. Mir. Tumor ablation with irreversible electroporation. PLoS ONE 2(11):e1135, 2007.
Appelbaum, L., E. Ben-David, M. Faroja, Y. Nissenbaum, and J. Sosna. Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays. Radiology 270(2):416–424, 2014.
Benz, R., F. Beckers, and U. Zimmermann. Reversible electrical breakdown of lipid bilayer membranes: a charge-pulse relaxation study. J. Membr. Biol. 48(2):181–204, 1979.
Cannon, R., S. Ellis, D. Hayes, and G. Narayanan. RC Martin. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J. Surg. Oncol. 107(5):544–549, 2013.
Davalos, R. V., B. Rubinsky, and L. M. Mir. Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 61(1–2):99–107, 2003.
Davalos, R. V., I. L. M. Mir, and B. Rubinsky. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33(2):223–231, 2005.
DeBruin, K. A., and W. Krassowska. Modeling electroporation in a single cell. I. Effects of field strength and rest potential. Biophys. J. 77(3):1213–1224, 1999.
Deodhar, A., S. Monette, G. W. Single, Jr., W. C. Hamilton, Jr., R. Thornton, M. Maybody, J. A. Coleman, and S. B. Solomon. Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77(3):754–760, 2011.
Devireddy, R. V. Statistical thermodynamics of biomembranes. Cryobiology 60(1):80–90, 2010.
Edd, J. F., L. Horowitz, R. V. Davalos, L. M. Mir, and B. Rubinsky. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans. Biomed. Eng. 53(7):1409–1415, 2006.
Ellis, T. L., P. A. Garcia, J. H. Rossmeisl, N. Henao-Guerrero, J. Robertson, and R. V. Davalos. Nonthermal irreversible electroporation for intracranial surgical applications. J. Neurosurg. 114(3):681–688, 2011.
Frandsen, S. K., H. Gissel, P. Hojman, T. Tramm, J. Eriksen, and J. Gehl. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res. 72(6):1336–1341, 2012.
Garcia, P. A., J. H. Rossmeisl, Jr., R. E. Neal, 2nd, T. L. Ellis, J. D. Olson, N. Henao-Guerrero, J. Robertson, and R. V. Davalos. Intracranial nonthermal irreversible electroporation: in vivo analysis. J. Membr. Biol. 236(1):127–136, 2010.
Gothelf, A., L. M. Mir, and J. Gehl. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat. Rev. 29(5):371–387, 2003.
Guo, Y., Y. Zhang, R. Klein, G. M. Nijm, A. V. Sahakian, R. A. Omary, G.-Y. Yang, and A. C. Larson. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res. 70(4):1555–1563, 2010.
Ivorra, A., B. Al-Sakere, B. Rubinsky, and L. M. Mir. In vivo electrical conductivity measurements during and after tumor electroporation: conductivity changes reflect the treatment outcome. Phys. Med. Biol. 54(19):5949–5963, 2009.
Jiang, C., Z. Qin, G. Long, and J. C. Bischof. An In Vitro Study on Adjuvant Enhanced Irreversible Electroporation. Presented at the Summer Bioengineering Conference. Farjardo, Puerto Rico, 2012.
Jiang, C., Z. Qin, and J. Bischof. Membrane-targeting approaches for enhanced cancer cell destruction with irreversible electroporation. Ann. Biomed. Eng. 42(1):193–204, 2014.
Jourabchi, N., K. Beroukhim, B. A. Tafti, S. T. Kee, and E. W. Lee. Irreversible electroporation (NanoKnife) in cancer treatment. Gastrointest. Interv. 3(1):8–18, 2014.
Karatekin, E., O. Sandre, H. Guitouni, N. Borghi, P.-H. Puech, and F. Brochard-Wyart. Cascades of transient pores in giant vesicles: line tension and transport. Biophys. J. 84(3):1734–1749, 2003.
Kinosita, Jr., K., and T. Y. Tsong. Voltage-induced conductance in human erythrocyte membranes. Biochim. Biophys. Acta (BBA) Biomembr 554(2):479–497, 1979.
Krassowska, W., and P. D. Filev. Modeling electroporation in a single cell. Biophys. J. 92(2):404–417, 2007.
Lavee, J., G. Onik, P. Mikus, and B. Rubinsky. A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. Heart Surg. Forum 10:162–167, 2007.
Lee, R. C. Cell injury by electric forces. Ann. NY. Acad. Sci. 1066:85–91, 2005.
Lee, R. C., D. Zhang, and J. Hannig. Biophysical injury mechanisms in electrical shock trauma. Ann. Rev. Biomed. Eng. 2(1):477–509, 2000.
Long, G., G. Bakos, P. K. Shires, L. Gritter, J. W. Crissman, J. L. Harris, and J. W. Clymer. Histological and finite element analysis of cell death due to irreversible electroporation. Technol. Cancer. Res. Treat. 13(6):561–569, 2014.
Miklavčič, D., D. Šemrov, H. Mekid, and L. M. Mir. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim. Biophys. Acta (BBA) 1523(1):73–83, 2000.
Miller, L., J. Leor, and B. Rubinsky. Cancer cells ablation with irreversible electroporation. Technol. Cancer Res. Treat. 4(6):699–705, 2005.
Neal, 2nd, R. E., R. Singh, H. C. Hatcher, N. D. Kock, S. V. Torti, and R. V. Davalos. Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode. Breast Cancer Res. Treat. 123(1):295–301, 2010.
Neal, R. E., P. A. Garcia, J. L. Robertson, and R. V. Davalos. Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning. IEEE Trans. Biomed. Eng. 59(4):1076–1085, 2012.
Onik, G., P. Mikus, and B. Rubinsky. Irreversible electroporation: implications for prostate ablation. Technol. Cancer Res. Treat. 6(4):295–300, 2007.
Qin, Z., J. Jiang, G. Long, B. Lindgren, and J. C. Bischof. Irreversible electroporation: an in vivo study with dorsal skin fold chamber. Ann. Biomed. Eng. 41(3):619–629, 2013.
Rubinsky, B., G. Onik, and P. Mikus. Irreversible electroporation: a new ablation modality—clinical implications. Technol. Cancer Res. Treat. 6(1):37–48, 2007.
Sano, M. B., R. E. Neal, 2nd, P. A. Garcia, D. Gerber, J. Robertson, and R. V. Davalos. Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed. Eng. Online 9:83, 2010.
Sapareto, S. A., and W. C. Dewey. Thermal dose determination in cancer therapy. Int. J. Radiat. Oncol. Biol. Phys. 10(6):787–800, 1984.
Scheffer, H. J., K. Nielsen, M. C. de Jong, A. A. van Tilborg, J. M. Vieveen, A. R. Bouwman, S. Meijer, C. van Kuijk, P. M. van den Tol, and M. R. Meijerink. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J. Vasc. Intervent. Radiol. 25(7):997–1011, 2014.
Serpersu, E. H., K. Kinosita, Jr., and T. Y. Tsong. Reversible and irreversible modification of erythrocyte membrane permeability by electric field. Biochim. Biophys. Acta (BBA) Biomembr. 812(3):779–785, 1985.
Sersa, G., T. Jarm, T. Kotnik, A. Coer, M. Podkrajsek, M. Sentjurc, D. Miklavcic, M. Kadivec, S. Kranjc, A. Secerov, and M. Cemazar. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br. J. Cancer 98(2):388–398, 2008.
Sersa, G., S. Kranjc, J. Scancar, M. Krzan, and M. Cemazar. Electrochemotherapy of mouse sarcoma tumors using electric pulse trains with repetition frequencies of 1 Hz and 5 kHz. J. Membr. Biol. 236(1):155–162, 2010.
Silve, A., A. Guimerà Brunet, B. Al-Sakere, A. Ivorra, and L. M. Mir. Comparison of the effects of the repetition rate between microsecond and nanosecond pulses: electropermeabilization-induced electro-desensitization? Biochim. Biophys. Acta (BBA) 1840(7):2139–2151, 2014.
Tsong, T. Y. Electroporation of cell membranes. Biophys. J. 60(2):297–306, 1991.
Weaver, J. C., K. C. Smith, A. T. Esser, R. S. Son, and T. R. Gowrishankar. A brief overview of electroporation pulse strength–duration space: a region where additional intracellular effects are expected. Bioelectrochemistry 87:236–243, 2012.
Yarmush, M. L., A. Golberg, G. Serša, T. Kotnik, and D. Miklavčič. Electroporation-based technologies for medicine: principles, applications, and challenges. Ann. Rev. Biomed. Eng. 16:295–320, 2014.
Acknowledgements
JCB was supported by the Carl and Janet Kuhrmeyer Chair in the Department of Mechanical Engineering at the University of Minnesota.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Cheng Dong oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Jiang, C., Shao, Q. & Bischof, J. Pulse Timing During Irreversible Electroporation Achieves Enhanced Destruction in a Hindlimb Model of Cancer. Ann Biomed Eng 43, 887–895 (2015). https://doi.org/10.1007/s10439-014-1133-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-014-1133-2